Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Chronic Renal Failure

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 199 articles:
HTML format
Text format



Single Articles


    October 2019
  1. MARWICK TH, Amann K, Bangalore S, Cavalcante JL, et al
    Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;96:836-849.
    PubMed     Text format     Abstract available


  2. SEKAR P, West BL, Henriksen KJ, Chang A, et al
    An incidental but pathognomonic finding in renal allograft biopsy.
    Kidney Int. 2019;96:1042.
    PubMed     Text format    


    September 2019
  3. PONTICELLI C, Moroni G
    Is preeclampsia a risk for end-stage renal disease?
    Kidney Int. 2019;96:547-549.
    PubMed     Text format     Abstract available


  4. DAVIES SJ
    Reaching consensus on the important outcomes for peritoneal dialysis patients.
    Kidney Int. 2019;96:545-546.
    PubMed     Text format     Abstract available


  5. WILLIAMS ME
    Said the glucose sensor to the insulin pump: can glycemic control be improved in hospitalized ESRD patients with diabetes mellitus?
    Kidney Int. 2019;96:540-542.
    PubMed     Text format     Abstract available


    August 2019
  6. ORLANDI PF, Huang J, Fukagawa M, Hoy W, et al
    A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30837.
    PubMed     Text format     Abstract available


  7. PORRINI E, Diaz JM, Moreso F, Lauzurrica R, et al
    Prediabetes is a risk factor for cardiovascular disease following renal transplantation.
    Kidney Int. 2019 Aug 14. pii: S0085-2538(19)30810.
    PubMed     Text format     Abstract available


  8. MENDLEY SR, Levin A, Correa-Rotter R, Joubert BR, et al
    Chronic kidney diseases in agricultural communities: report from a workshop.
    Kidney Int. 2019 Aug 2. pii: S0085-2538(19)30781.
    PubMed     Text format     Abstract available


  9. TAN J
    Forty-billion medical expenditure for dialysis patients in China.
    Kidney Int. 2019;96:523.
    PubMed     Text format    


  10. SEPE V, Rampino T, Libetta C
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019;96:522.
    PubMed     Text format    


  11. PHILIP NM, Naranje P, Bagchi S, Das CJ, et al
    Multiple abscesses in a renal transplant recipient.
    Kidney Int. 2019;96:526.
    PubMed     Text format    


    July 2019
  12. ALENCAR DE PINHO N, Levin A, Fukagawa M, Hoy WE, et al
    Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.
    Kidney Int. 2019 Jul 25. pii: S0085-2538(19)30512.
    PubMed     Text format     Abstract available


  13. FAUCON AL, Flamant M, Metzger M, Boffa JJ, et al
    Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
    Kidney Int. 2019 Jul 16. pii: S0085-2538(19)30704.
    PubMed     Text format     Abstract available


  14. KAUNDAL U, Ramachandran R, Arora A, Kenwar DB, et al
    B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients.
    Kidney Int. 2019;96:249-250.
    PubMed     Text format    


  15. SUGIYAMA T
    Chronic kidney disease and fracture risk: a mechanistic insight.
    Kidney Int. 2019;96:247.
    PubMed     Text format    


  16. WALTHER CP, Erickson KF
    The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins.
    Kidney Int. 2019;96:22-25.
    PubMed     Text format     Abstract available


    June 2019
  17. SHIRAZIAN S
    Depression in patients undergoing hemodialysis: time to treat.
    Kidney Int. 2019 Jun 3. pii: S0085-2538(19)30592.
    PubMed     Text format    



  18. Wyatt CM, Drueke TB. High-dose IV iron for anemia correction in chronic kidney disease. Kidney Int. 2019;95:727-730.
    Kidney Int. 2019;95:1518.
    PubMed     Text format    


  19. RAPHAEL KL
    The Dietary Approaches to Stop Hypertension (DASH) diet in chronic kidney disease: should we embrace it?
    Kidney Int. 2019;95:1296-1298.
    PubMed     Text format     Abstract available


    May 2019
  20. WADDY SP, Ward JB, Becerra AZ, Powers T, et al
    Epilepsy and antiseizure medications increase all-cause mortality in dialysis patients in the United States.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30514.
    PubMed     Text format     Abstract available


  21. ROSSING P, Block GA, Chin MP, Goldsberry A, et al
    Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30503.
    PubMed     Text format     Abstract available


  22. SISE ME, Chute DF, Oppong Y, Davis MI, et al
    Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30508.
    PubMed     Text format     Abstract available


  23. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Text format     Abstract available


  24. EGLI-SPICHTIG D, Imenez Silva PH, Glaudemans B, Gehring N, et al
    Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.
    Kidney Int. 2019 May 14. pii: S0085-2538(19)30465.
    PubMed     Text format     Abstract available


  25. COVELLA B, Vinturache AE, Cabiddu G, Attini R, et al
    A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia.
    Kidney Int. 2019 May 14. pii: S0085-2538(19)30502.
    PubMed     Text format     Abstract available


  26. FAZZINI F, Lamina C, Fendt L, Schultheiss UT, et al
    Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30483.
    PubMed     Text format     Abstract available


  27. HALLAN SI, Rifkin DE, Potok OA, Katz R, et al
    Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30484.
    PubMed     Text format     Abstract available


  28. CHEUNG AK, Chang TI, Cushman WC, Furth SL, et al
    Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;95:1027-1036.
    PubMed     Text format     Abstract available


  29. MAZZAFERRO S, Pasquali M
    Direct bone effects of calcimimetics in chronic kidney disease?
    Kidney Int. 2019;95:1012-1014.
    PubMed     Text format     Abstract available


    April 2019
  30. HOUSE AA, Wanner C, Sarnak MJ, Pina IL, et al
    Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276.
    PubMed     Text format     Abstract available


  31. CHAN CT, Blankestijn PJ, Dember LM, Gallieni M, et al
    Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 12. pii: S0085-2538(19)30138.
    PubMed     Text format     Abstract available


  32. JEONG JH, Biruete A, Tomayko EJ, Wu PT, et al
    Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients.
    Kidney Int. 2019 Apr 2. pii: S0085-2538(19)30389.
    PubMed     Text format     Abstract available


  33. JADOUL M, Bieber BA, Martin P, Akiba T, et al
    Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
    Kidney Int. 2019;95:939-947.
    PubMed     Text format     Abstract available


  34. ROSSIGNOL P, Frimat L, Zannad F
    The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
    Kidney Int. 2019;95:747-749.
    PubMed     Text format     Abstract available


  35. HE H, Li B, Gao X, Li H, et al
    A dialysis patient with isolated persistent left superior vena cava.
    Kidney Int. 2019;95:1000.
    PubMed     Text format    


  36. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.
    PubMed     Text format    



  37. Caplin B, Yang C-W, Anand S, et al., on behalf of International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology (i3C). The International Society of Nephrology's International Consortium o
    Kidney Int. 2019;95:997-998.
    PubMed     Text format    


  38. LANDAU SI, Guo X, Velazquez H, Torres R, et al
    Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
    Kidney Int. 2019;95:797-814.
    PubMed     Text format     Abstract available


  39. WYATT CM, Drueke TB
    High-dose IV iron for anemia correction in chronic kidney disease.
    Kidney Int. 2019;95:727-730.
    PubMed     Text format    


  40. SINGH G, Swamy A, Kumari K, Brijwal M, et al
    The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney Int. 2019;95:1001-1002.
    PubMed     Text format    


    March 2019
  41. MANERA KE, Tong A, Craig JC, Shen J, et al
    An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis.
    Kidney Int. 2019 Mar 29. pii: S0085-2538(19)30340.
    PubMed     Text format     Abstract available


  42. MAYER GJ, Wanner C, Weir MR, Inzucchi SE, et al
    Analysis from the EMPA-REG OUTCOME((R)) trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.
    Kidney Int. 2019 Mar 21. pii: S0085-2538(19)30317.
    PubMed     Text format     Abstract available


  43. AZUKAITIS K, Ju W, Kirchner M, Nair V, et al
    Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30184.
    PubMed     Text format     Abstract available


  44. BALLY L, Gubler P, Thabit H, Hartnell S, et al
    Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30322.
    PubMed     Text format     Abstract available


  45. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Text format     Abstract available


  46. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Text format     Abstract available


  47. SCHLACKOW I, Kent S, Herrington W, Emberson J, et al
    Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
    Kidney Int. 2019 Mar 12. pii: S0085-2538(19)30171.
    PubMed     Text format     Abstract available


  48. ROSSING P, Persson F, Frimodt-Moller M
    Improvements in albuminuria and chronic kidney disease progression with the appetite suppressant lorcaserin.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30281.
    PubMed     Text format    


  49. ROWE C, Sitch AJ, Barratt J, Brettell EA, et al
    Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30274.
    PubMed     Text format     Abstract available


  50. BAI M, Chen H, Ding D, Song R, et al
    MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30114.
    PubMed     Text format     Abstract available


  51. LOUTRADIS C, Sarafidis PA, Ekart R, Papadopoulos C, et al
    The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30270.
    PubMed     Text format     Abstract available


  52. AGARWAL AK, Haddad NJ, Vachharajani TJ, Asif A, et al
    Innovations in vascular access for hemodialysis.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30103.
    PubMed     Text format     Abstract available


  53. MULAY SR
    Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30109.
    PubMed     Text format     Abstract available


  54. BANERJEE T, Crews DC, Tuot DS, Pavkov ME, et al
    Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30113.
    PubMed     Text format     Abstract available


  55. COMBALIA A, Munoz-Mahamud E, Cofan F
    Giant calcified mass in a hemodialysis patient.
    Kidney Int. 2019;95:719.
    PubMed     Text format    


  56. CHAMARTHI G, Koratala A
    Embedded peritoneal dialysis catheter.
    Kidney Int. 2019;95:718.
    PubMed     Text format    


  57. GORAYA N, Simoni J, Sager LN, Madias NE, et al
    Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Kidney Int. 2019 Mar 1. pii: S0085-2538(18)30945.
    PubMed     Text format     Abstract available


    February 2019
  58. SANCHIS P, Ho CY, Liu Y, Beltran LE, et al
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019 Feb 28. pii: S0085-2538(19)30035.
    PubMed     Text format     Abstract available


  59. XU H, Kuja-Halkola R, Chen X, Magnusson PKE, et al
    Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30047.
    PubMed     Text format     Abstract available


  60. KIKUCHI K, Hamano T, Wada A, Nakai S, et al
    Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis.
    Kidney Int. 2019 Feb 16. pii: S0085-2538(18)30897.
    PubMed     Text format     Abstract available


  61. CONNAUGHTON DM, Kennedy C, Shril S, Mann N, et al
    Monogenic causes of chronic kidney disease in adults.
    Kidney Int. 2019 Feb 12. pii: S0085-2538(18)30839.
    PubMed     Text format     Abstract available


  62. TANASIYCHUK T, Kushnir DA, Antebi A, Frajewicki V, et al
    Paradoxically normal location of peritoneal dialysis catheter.
    Kidney Int. 2019;95:470.
    PubMed     Text format    


  63. EVENEPOEL P, Claes K, Cavalier E, Meijers B, et al
    A distinct bone phenotype in ADPKD patients with end-stage renal disease.
    Kidney Int. 2019;95:412-419.
    PubMed     Text format     Abstract available


  64. CANAUD B, Kooman J, Selby NM, Taal M, et al
    Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease.
    Kidney Int. 2019;95:296-309.
    PubMed     Text format     Abstract available


  65. HRUSKA KA, Mahjoub MR
    New pathogenic insights inform therapeutic target development for renal osteodystrophy.
    Kidney Int. 2019;95:261-263.
    PubMed     Text format     Abstract available


  66. NUVOLONE M, Merlini G
    Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Kidney Int. 2019;95:258-260.
    PubMed     Text format     Abstract available


    January 2019
  67. HAMMER F, Malzahn U, Donhauser J, Betz C, et al
    A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.
    Kidney Int. 2019 Jan 29. pii: S0085-2538(18)30906.
    PubMed     Text format     Abstract available


  68. CONNOLLY R, Denton MD, Humphreys H, McLoughlin RM, et al
    Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?
    Kidney Int. 2019 Jan 26. pii: S0085-2538(18)30824.
    PubMed     Text format     Abstract available


  69. VIECELLI AK, Lok CE
    Hemodialysis vascular access in the elderly-getting it right.
    Kidney Int. 2019;95:38-49.
    PubMed     Text format     Abstract available


  70. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Text format     Abstract available


  71. CAPLIN B, Yang CW, Anand S, Levin A, et al
    The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dat
    Kidney Int. 2019;95:4-10.
    PubMed     Text format    


  72. CHEN Z, Zhang W, Chen X, Hsu CY, et al
    Trends in end-stage kidney disease in Shanghai, China.
    Kidney Int. 2019;95:232.
    PubMed     Text format    


  73. WANG J, Zhang L, Zhao MH
    The authors reply.
    Kidney Int. 2019;95:233.
    PubMed     Text format    


  74. TAKANO T, Bareke E, Takeda N, Aoudjit L, et al
    Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice.
    Kidney Int. 2019;95:57-61.
    PubMed     Text format     Abstract available


  75. SEE EJ, Jayasinghe K, Glassford N, Bailey M, et al
    Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure.
    Kidney Int. 2019;95:160-172.
    PubMed     Text format     Abstract available


    December 2018
  76. VERZOLA D, Barisione C, Picciotto D, Garibotto G, et al
    Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
    Kidney Int. 2018 Dec 28. pii: S0085-2538(18)30777.
    PubMed     Text format     Abstract available


  77. WHITLOCK RH, Leslie WD, Shaw J, Rigatto C, et al
    The Fracture Risk Assessment Tool (FRAX(R)) predicts fracture risk in patients with chronic kidney disease.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30775.
    PubMed     Text format     Abstract available


  78. LIAKOPOULOS V, Eleftheriadis T, Mertens PR
    Screening for renal cell carcinoma in dialysis patients.
    Kidney Int. 2018;94:1238.
    PubMed     Text format    


  79. KRONBICHLER A, Jayne DRW
    ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?
    Kidney Int. 2018;94:1045-1047.
    PubMed     Text format     Abstract available


  80. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.
    PubMed     Text format    


  81. YEN TH, Wang IK, Hsu CW
    Hemoperfusion for paraquat poisoning.
    Kidney Int. 2018;94:1239.
    PubMed     Text format    


  82. FISCHER RSB, Vangala C, Mandayam S, Chavarria D, et al
    Clinical markers to predict progression from acute to chronic kidney disease in Mesoamerican nephropathy.
    Kidney Int. 2018;94:1205-1216.
    PubMed     Text format     Abstract available


    November 2018
  83. CHARYTAN DM, Himmelfarb J, Ikizler TA, Raj DS, et al
    Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
    Kidney Int. 2018 Nov 22. pii: S0085-2538(18)30641.
    PubMed     Text format     Abstract available


  84. KIKUCHI H, Sasaki E, Nomura N, Mori T, et al
    Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease.
    Kidney Int. 2018 Nov 13. pii: S0085-2538(18)30635.
    PubMed     Text format     Abstract available


  85. JIANG G, Luk AOY, Tam CHT, Xie F, et al
    Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30629.
    PubMed     Text format     Abstract available


  86. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Text format     Abstract available


  87. BOUCHARA A, Yi D, Pastural M, Granjon S, et al
    Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients.
    Kidney Int. 2018;94:983-992.
    PubMed     Text format     Abstract available


  88. WANG T, Zhan ZP, Yang L, Lu Y, et al
    Extreme manifestations of hyperparathyroidism in a hemodialysis patient.
    Kidney Int. 2018;94:1028.
    PubMed     Text format    


  89. SCHMITT R
    ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
    Kidney Int. 2018;94:858-860.
    PubMed     Text format     Abstract available


  90. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Text format     Abstract available


  91. KRAMER H, Soyibo A, Forrester T, Boyne M, et al
    The burden of chronic kidney disease and its major risk factors in Jamaica.
    Kidney Int. 2018;94:840-842.
    PubMed     Text format    



  92. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451.
    Kidney Int. 2018;94:1025-1026.
    PubMed     Text format    


    October 2018
  93. AGARWAL R, Tu W
    Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30608.
    PubMed     Text format     Abstract available


  94. BRIX SR, Noriega M, Tennstedt P, Vettorazzi E, et al
    Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30552.
    PubMed     Text format     Abstract available


  95. VYCHYTIL A, Herzog R, Probst P, Ribitsch W, et al
    A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
    Kidney Int. 2018 Oct 22. pii: S0085-2538(18)30637.
    PubMed     Text format     Abstract available


  96. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Text format     Abstract available


  97. KHAN SF, Rosner MH
    "Highlighting" an unusual case of discolored peritoneal dialysis effluent.
    Kidney Int. 2018;94:835.
    PubMed     Text format    


  98. PARFREY PS
    Evocalcet in the management of secondary hyperparathyroidism in dialysis patients.
    Kidney Int. 2018;94:661-662.
    PubMed     Text format     Abstract available


  99. ELEFTHERIADIS T, Pissas G, Liakopoulos V, Stefanidis I, et al
    Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia.
    Kidney Int. 2018;94:830-831.
    PubMed     Text format    


  100. SELISTRE L, Rabilloud M, De Souza V, Iwaz J, et al
    Regarding "Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease".
    Kidney Int. 2018;94:827-828.
    PubMed     Text format    


    September 2018
  101. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Text format     Abstract available


  102. SHAIKH M, Woodward M, John O, Bassi A, et al
    Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
    Kidney Int. 2018;94:440-445.
    PubMed     Text format    


    August 2018
  103. BLAKE PG
    Is the peritoneal dialysis biocompatibility hypothesis dead?
    Kidney Int. 2018;94:246-248.
    PubMed     Text format     Abstract available


  104. NIGWEKAR SU, Nazarian RM
    Cutaneous calcification in patients with kidney disease is not always calciphylaxis.
    Kidney Int. 2018;94:244-246.
    PubMed     Text format     Abstract available


    July 2018
  105. JHA V, Modi GK
    Getting to know the enemy better-the global burden of chronic kidney disease.
    Kidney Int. 2018 Jul 24. pii: S0085-2538(18)30362.
    PubMed     Text format     Abstract available


  106. YAMADA S, Leaf EM, Chia JJ, Cox TC, et al
    PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.
    Kidney Int. 2018 Jul 21. pii: S0085-2538(18)30389.
    PubMed     Text format     Abstract available


  107. FUKAGAWA M, Shimazaki R, Akizawa T
    Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30387.
    PubMed     Text format     Abstract available


  108. XIE Y, Bowe B, Mokdad AH, Xian H, et al
    Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.
    Kidney Int. 2018 Jul 5. pii: S0085-2538(18)30318.
    PubMed     Text format     Abstract available


  109. TANEMOTO M
    The analysis of hemoglobin A1c in dialysis patients should include the variables that reflect the erythrocyte turnover.
    Kidney Int. 2018;94:220-221.
    PubMed     Text format    


  110. RAYNER HC, Rosansky SJ
    The estimated glomerular filtration rate graph: another tool in the management of patients with advanced chronic kidney disease.
    Kidney Int. 2018;94:222.
    PubMed     Text format    


  111. HAWKINS CL
    Protein carbamylation: a key driver of vascular calcification during chronic kidney disease.
    Kidney Int. 2018;94:12-14.
    PubMed     Text format     Abstract available


    June 2018
  112. WANNER C, Herzog CA, Turakhia MP
    Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2018 Jun 20. pii: S0085-2538(18)30358.
    PubMed     Text format    


  113. KARABOYAS A, Xu H, Morgenstern H, Locatelli F, et al
    DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
    Kidney Int. 2018 Jun 13. pii: S0085-2538(18)30253.
    PubMed     Text format     Abstract available


  114. HU JR, Coresh J, Inker LA, Levey AS, et al
    Serum metabolites are associated with all-cause mortality in chronic kidney disease.
    Kidney Int. 2018 Jun 2. pii: S0085-2538(18)30247.
    PubMed     Text format     Abstract available


  115. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Text format     Abstract available


  116. WYATT CM, Wanner N
    Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults.
    Kidney Int. 2018;93:1260-1262.
    PubMed     Text format    


  117. QIU C, Hanson RL, Fufaa G, Kobes S, et al
    Cytosine methylation predicts renal function decline in American Indians.
    Kidney Int. 2018;93:1417-1431.
    PubMed     Text format     Abstract available


  118. NADKARNI GN, Chauhan K, Verghese DA, Parikh CR, et al
    Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Kidney Int. 2018;93:1409-1416.
    PubMed     Text format     Abstract available


    May 2018
  119. RABY AC, Gonzalez-Mateo GT, Williams A, Topley N, et al
    Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30254.
    PubMed     Text format     Abstract available


  120. DURLACHER-BETZER K, Hassan A, Levi R, Axelrod J, et al
    Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30240.
    PubMed     Text format     Abstract available


  121. TAM-THAM H, Quinn RR, Weaver RG, Zhang J, et al
    Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.
    Kidney Int. 2018 May 23. pii: S0085-2538(18)30246.
    PubMed     Text format     Abstract available


  122. ALEKSOVA J, Wong P, McLachlan R, Choy KW, et al
    Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30212.
    PubMed     Text format     Abstract available


  123. SCHAEFER B, Bartosova M, Macher-Goeppinger S, Sallay P, et al
    Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30213.
    PubMed     Text format     Abstract available


  124. ZHU L, Guo WY, Shi SF, Liu LJ, et al
    Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30214.
    PubMed     Text format     Abstract available


  125. GUMBER R, Cohen JB, Palmer MB, Kobrin SM, et al
    A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30211.
    PubMed     Text format     Abstract available


  126. ALRIC L, Ollivier-Hourmand I, Berard E, Hillaire S, et al
    Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30209.
    PubMed     Text format     Abstract available


  127. NG DK, Schwartz GJ, Schneider MF, Furth SL, et al
    Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30184.
    PubMed     Text format     Abstract available


  128. GOODKIN DA, Bieber B
    International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
    Kidney Int. 2018;93:1249.
    PubMed     Text format    


  129. FUSARO M, Cannata-Andia JB, Nickolas TL, Plebani M, et al
    Clinical relevance and future perspective of fractures in patients with chronic kidney disease.
    Kidney Int. 2018;93:1248.
    PubMed     Text format    


  130. STENGEL B
    Uncovering real mortality trends in ESRD patients.
    Kidney Int. 2018;93:1040-1043.
    PubMed     Text format     Abstract available


  131. HOMMOS MS, Zeng C, Liu Z, Troost JP, et al
    Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Kidney Int. 2018;93:1175-1182.
    PubMed     Text format     Abstract available


    April 2018
  132. NEVEN E, Vervaet B, Brand K, Gottwald-Hostalek U, et al
    Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30174.
    PubMed     Text format     Abstract available


  133. BARUTTA F, Bruno G, Mastrocola R, Bellini S, et al
    The role of cannabinoid signaling in acute and chronic kidney diseases.
    Kidney Int. 2018 Apr 26. pii: S0085-2538(18)30140.
    PubMed     Text format     Abstract available


  134. BRUCK K, Jager KJ, Zoccali C, Bello AK, et al
    Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30096.
    PubMed     Text format     Abstract available


  135. KALRA PA, Green D, Poulikakos D
    Arrhythmia in hemodialysis patients and its relation to sudden death.
    Kidney Int. 2018;93:781-783.
    PubMed     Text format     Abstract available


  136. LABRIOLA L, Jadoul M
    Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered.
    Kidney Int. 2018;93:1015-1016.
    PubMed     Text format    


  137. MATHEW RO, Bangalore S, Sidhu MS, Fleg JL, et al
    Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Kidney Int. 2018;93:787-788.
    PubMed     Text format    


  138. WATERS DD, Vogt L
    Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
    Kidney Int. 2018;93:784-786.
    PubMed     Text format     Abstract available


  139. PRASAD PV
    Update on renal blood oxygenation level-dependent MRI to assess intrarenal oxygenation in chronic kidney disease.
    Kidney Int. 2018;93:778-780.
    PubMed     Text format     Abstract available


  140. GRAUDAL N
    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    PubMed     Text format     Abstract available


  141. OOMATIA A, Dupont P, Bass P, Moochhala S, et al
    The Case | Shining a light on an unusual case of chronic kidney disease.
    Kidney Int. 2018;93:1023-1024.
    PubMed     Text format    


  142. VACHHARAJANI TJ, Agarwal AK, Asif A
    Vascular access of last resort.
    Kidney Int. 2018;93:797-802.
    PubMed     Text format     Abstract available


    March 2018
  143. GRAMS ME, Sang Y, Ballew SH, Carrero JJ, et al
    Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
    Kidney Int. 2018 Mar 24. pii: S0085-2538(18)30097.
    PubMed     Text format     Abstract available


  144. VERVLOET MG, van Ballegooijen AJ
    Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Kidney Int. 2018 Mar 23. pii: S0085-2538(18)30124.
    PubMed     Text format     Abstract available


  145. WANG J, Zhang L, Tang SC, Kashihara N, et al
    Disease burden and challenges of chronic kidney disease in North and East Asia.
    Kidney Int. 2018 Mar 21. pii: S0085-2538(18)30094.
    PubMed     Text format    


  146. PUN PH, Wyatt CM
    Utility of implantable cardioverter defibrillators in chronic kidney disease.
    Kidney Int. 2018 Mar 17. pii: S0085-2538(18)30196.
    PubMed     Text format    


  147. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Text format     Abstract available


  148. TOTH PP, Dwyer JP, Cannon CP, Colhoun HM, et al
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Kidney Int. 2018 Mar 8. pii: S0085-2538(18)30055.
    PubMed     Text format     Abstract available


  149. TONELLI M, Wiebe N, James MT, Klarenbach SW, et al
    A population-based cohort study defines prognoses in severe chronic kidney disease.
    Kidney Int. 2018 Mar 7. pii: S0085-2538(18)30057.
    PubMed     Text format     Abstract available


    February 2018
  150. RABBANI N, Thornalley PJ
    Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30051.
    PubMed     Text format     Abstract available


  151. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    PubMed     Text format     Abstract available


  152. SUMIDA K, Molnar MZ, Potukuchi PK, Hassan F, et al
    Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30893.
    PubMed     Text format     Abstract available


  153. NITSCH D
    Does dialysis modality affect the development of cognitive impairment?
    Kidney Int. 2018;93:306-308.
    PubMed     Text format     Abstract available


  154. DUSSO A, Colombo MI, Shanahan CM
    Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.
    Kidney Int. 2018;93:298-301.
    PubMed     Text format     Abstract available


  155. ORDUNEZ P, Hoy WE
    Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.
    Kidney Int. 2018;93:284-287.
    PubMed     Text format    


    January 2018
  156. STOREY BC, Staplin N, Harper CH, Haynes R, et al
    Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Kidney Int. 2018 Jan 30. pii: S0085-2538(17)30856.
    PubMed     Text format     Abstract available


  157. ROY-CHAUDHURY P, Tumlin JA, Koplan BA, Costea AI, et al
    Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30855.
    PubMed     Text format     Abstract available


  158. DOU L, Poitevin S, Sallee M, Addi T, et al
    Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30826.
    PubMed     Text format     Abstract available


  159. LIU BC, Tang TT, Lv LL, Lan HY, et al
    Renal tubule injury: a driving force toward chronic kidney disease.
    Kidney Int. 2018 Jan 17. pii: S0085-2538(17)30819.
    PubMed     Text format     Abstract available


  160. PRUIJM M, Milani B, Pivin E, Podhajska A, et al
    Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30800.
    PubMed     Text format     Abstract available


  161. LEE BJ, Go AS, Parikh R, Leong TK, et al
    Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30797.
    PubMed     Text format     Abstract available


  162. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Text format     Abstract available


  163. PERSSON F, Borg R
    YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
    Kidney Int. 2018;93:21-22.
    PubMed     Text format     Abstract available


  164. MARSHALL MR
    Intensive hemodialysis-keeping the faith.
    Kidney Int. 2018;93:10-12.
    PubMed     Text format     Abstract available


  165. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.
    PubMed     Text format    


  166. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.
    PubMed     Text format    


  167. FARRAH TE, Anand A, Miller-Hodges E, Mills NL, et al
    Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.
    Kidney Int. 2018;93:270.
    PubMed     Text format    


  168. CHEN Z, Li J, Yang Y, Li H, et al
    The renal artery is involved in Chinese Takayasu's arteritis patients.
    Kidney Int. 2018;93:245-251.
    PubMed     Text format     Abstract available


  169. TENNANKORE KK, Na Y, Wald R, Chan CT, et al
    Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival.
    Kidney Int. 2018;93:188-194.
    PubMed     Text format     Abstract available


    December 2017
  170. YU ASL, Shen C, Landsittel DP, Harris PC, et al
    Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Kidney Int. 2017 Dec 28. pii: S0085-2538(17)30785.
    PubMed     Text format     Abstract available


  171. ANDERS HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, et al
    The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30772.
    PubMed     Text format     Abstract available


  172. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Text format     Abstract available



  173. Moradi H, Said HM. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016;90:252-254.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    



  174. Li L, Lai EY, Luo Z, et al. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Kidney Int. 2017;92:625-633.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    



  175. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26-36.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    


  176. ISAKA Y
    Adaptor protein is a new therapeutic target in chronic kidney disease.
    Kidney Int. 2017;92:1312-1314.
    PubMed     Text format     Abstract available


    November 2017
  177. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    PubMed     Text format     Abstract available


  178. WAGENSEIL JE
    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    PubMed     Text format     Abstract available


  179. LIN TY, Peng CH, Hung SC, Tarng DC, et al
    Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30663.
    PubMed     Text format     Abstract available


    October 2017
  180. SAWINSKI D, Forde KA, Locke JE, Cohen JB, et al
    Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
    Kidney Int. 2017 Oct 26. pii: S0085-2538(17)30612.
    PubMed     Text format     Abstract available


  181. NEUMANN D, Mau W, Wienke A, Girndt M, et al
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Kidney Int. 2017 Oct 14. pii: S0085-2538(17)30568.
    PubMed     Text format     Abstract available


  182. CHARYTAN DM, Skali H, Shah NR, Veeranna V, et al
    Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Kidney Int. 2017 Oct 13. pii: S0085-2538(17)30571.
    PubMed     Text format     Abstract available


  183. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    PubMed     Text format     Abstract available


  184. STREJA E
    Hospital readmission for the dialysis patient: who is (not) responsible?
    Kidney Int. 2017;92:788-790.
    PubMed     Text format     Abstract available


    September 2017
  185. PIMENTEL A, Urena-Torres P, Zillikens MC, Bover J, et al
    Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Kidney Int. 2017 Sep 27. pii: S0085-2538(17)30567.
    PubMed     Text format     Abstract available


  186. LORENZ G, Schmalenberg M, Kemmner S, Haller B, et al
    Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
    Kidney Int. 2017 Sep 20. pii: S0085-2538(17)30540.
    PubMed     Text format     Abstract available


  187. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    PubMed     Text format     Abstract available


  188. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    PubMed     Text format     Abstract available


    July 2017
  189. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


    April 2017
  190. BIERZYNSKA A, McCarthy HJ, Soderquest K, Sen ES, et al
    Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Kidney Int. 2017;91:937-947.
    PubMed     Text format     Abstract available


    March 2017
  191. LOWENSTEIN J, Grantham JJ
    Residual renal function: a paradigm shift.
    Kidney Int. 2017;91:561-565.
    PubMed     Text format     Abstract available


  192. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Text format     Abstract available


    February 2017
  193. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    PubMed     Text format     Abstract available


  194. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    PubMed     Text format     Abstract available


  195. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    PubMed     Text format     Abstract available


    November 2016
  196. READY AR, Nath J, Milford DV, Adu D, et al
    Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Kidney Int. 2016;90:916-920.
    PubMed     Text format    


    August 2016
  197. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.
    PubMed     Text format    


    July 2016
  198. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Text format     Abstract available


    April 2016
  199. GILL J, Dong J, Rose C, Gill JS, et al
    The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Kidney Int. 2016 Apr 5. pii: S0085-2538(16)00324.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: